期刊文献+

纳豆激酶分离纯化及其兔抗血清的制备 被引量:1

Isolation and Purification of Nattokinase and Preparation of Rabbit Antiserum Against It
暂未订购
导出
摘要 为分离纯化纳豆激酶,使用纳豆激酶粗制液经硫酸铵分级盐析、Sephodex G100和CM-Sephrose-6B FF层析等步骤纯化,经SDS-聚丙烯酰胺凝胶电泳检测。以纯化的纳豆激酶作为抗原,结合福氏佐剂,采用多次多点肌肉注射法对兔进行免疫,以琼脂免疫双向扩散法检测效价。试验结果表明,纳豆激酶粗制液经纯化后,得纯酶样品,酶被纯化了28.4倍,比活力为608.6 Uku.mg-1蛋白,SDS-聚丙烯酰胺凝胶电泳检测为单一蛋白条带,纳豆激酶兔抗血清效价为1∶64。成功制备的兔抗纳豆激酶抗血清,为研究纳豆激酶的功能提供了物质基础。 To separate and purify the Nattokinase and to prepare antiserum against Nattokinase. Nattokinase was purified through procedures including ammonium sulfate differential precipitation, sephadexG-100, and CM-Sephrose-6B FF chromatography, and was detected on gels of SDS-PAGE. Rabbit antiserum against Nattokinase was prepared by muscle immunization mixed with Freund's adjuvant and the titer was detected by double immunodiffusion carried out on agar gel. The purified sample's specific activity was 608.6 UKu·mg^-1 protein and was purified by 28. 4 fold. The purified nattokinase showed single protein band on gels of SDS-PAGE. The titer of rabbit antiserum against Nattokinase was 1 : 64. The rabbit antiserum against Nattokinase is prepared successfully, and it provides the material foundation to the function study of Nattokinase.
出处 《山西农业大学学报(自然科学版)》 CAS 2009年第4期308-311,共4页 Journal of Shanxi Agricultural University(Natural Science Edition)
基金 山西省青年科学基金(20041036)
关键词 纳豆激酶 分离纯化 抗血清 Nattokinase separation and purification antiserum
  • 相关文献

参考文献7

二级参考文献21

  • 1刘玉军,孙明堂,张枢泉,杨惠彬,董小燕,穆照梅.浓缩鱼油对实验性动脉粥样硬化的影响及机理探讨[J].营养学报,1994,16(1):6-12. 被引量:22
  • 2刘城.[D].南京农业大学食品科技学院,2000.
  • 3Iwai K, Nakaya N, KawasakiY, etal. Antioxidative functions of natto, a kind of fermented soybeans: effect on LDL oxidation and lipid metabolism in cholesterol-fed rats[J].J Agric Food Chem, 2002,50:3597-3601.
  • 4Okamoto A, Hanagata H, Kawamura Y. et al.Anti-hypertensive substances in fermented soybean, natto[J]. Plant FoodsHum Nutr, 1995,47:39-47.
  • 5Urano T, Ihara H, Umenura K, et al. The pro-fibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1[J]. J Biol Chem, 2001, 276: 24690-24696.
  • 6Hoff HF, O Neil J. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macropages[J].Atherosclerosis, 1988,70:29.
  • 7Meade TW, Vickers MV, Thompson SG, et al. The effect of physiological levels of fibrinogen on platelet aggregation [J]. Thromb Res, 1985,38:527-534.
  • 8Hamsten A. The hemostatic system and coronary heart disease[J]. Thromb Res, 1993,70:1-38.
  • 9Chien H. Hemorrheology in clinical medicine[J].Clin Hemorrheol, 1982, 2:137.
  • 10Keaney JF, Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection[J]. Prog Cardiovasc Dis, 1995,38:129- 148.

共引文献75

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部